1. Home
  2. MTVA vs SOHO Comparison

MTVA vs SOHO Comparison

Compare MTVA & SOHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTVA
  • SOHO
  • Stock Information
  • Founded
  • MTVA 2014
  • SOHO 2004
  • Country
  • MTVA United States
  • SOHO United States
  • Employees
  • MTVA N/A
  • SOHO N/A
  • Industry
  • MTVA
  • SOHO Real Estate Investment Trusts
  • Sector
  • MTVA
  • SOHO Real Estate
  • Exchange
  • MTVA NYSE
  • SOHO Nasdaq
  • Market Cap
  • MTVA 16.8M
  • SOHO 16.1M
  • IPO Year
  • MTVA N/A
  • SOHO 2004
  • Fundamental
  • Price
  • MTVA $1.60
  • SOHO $0.83
  • Analyst Decision
  • MTVA Strong Buy
  • SOHO Hold
  • Analyst Count
  • MTVA 1
  • SOHO 1
  • Target Price
  • MTVA $12.00
  • SOHO $1.50
  • AVG Volume (30 Days)
  • MTVA 23.0K
  • SOHO 45.1K
  • Earning Date
  • MTVA 03-27-2025
  • SOHO 03-13-2025
  • Dividend Yield
  • MTVA N/A
  • SOHO N/A
  • EPS Growth
  • MTVA N/A
  • SOHO N/A
  • EPS
  • MTVA N/A
  • SOHO N/A
  • Revenue
  • MTVA N/A
  • SOHO $179,860,606.00
  • Revenue This Year
  • MTVA N/A
  • SOHO N/A
  • Revenue Next Year
  • MTVA N/A
  • SOHO $0.70
  • P/E Ratio
  • MTVA N/A
  • SOHO N/A
  • Revenue Growth
  • MTVA N/A
  • SOHO 3.98
  • 52 Week Low
  • MTVA $1.51
  • SOHO $0.78
  • 52 Week High
  • MTVA $6.75
  • SOHO $1.54
  • Technical
  • Relative Strength Index (RSI)
  • MTVA N/A
  • SOHO 46.61
  • Support Level
  • MTVA N/A
  • SOHO $0.78
  • Resistance Level
  • MTVA N/A
  • SOHO $0.86
  • Average True Range (ATR)
  • MTVA 0.00
  • SOHO 0.04
  • MACD
  • MTVA 0.00
  • SOHO 0.01
  • Stochastic Oscillator
  • MTVA 0.00
  • SOHO 45.36

About MTVA METAVIA INC

MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.

About SOHO Sotherly Hotels Inc.

Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.

Share on Social Networks: